Neuphoria Therapeutics Inc. Investment Income, Interest
Neuphoria Therapeutics Inc. (NEUP) reported Investment Income, Interest of $665.57 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-18.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-09-18
- Neuphoria Therapeutics Inc. investment income, interest for the quarter ending 2026-06-30 was $170.09K, a 95.41% increase year-over-year.
- Neuphoria Therapeutics Inc. investment income, interest for the quarter ending 2026-03-31 was $186.17K, a 1361.20% increase year-over-year.
- Neuphoria Therapeutics Inc. investment income, interest for the quarter ending 2025-12-31 was $167.31K, a 446.50% increase year-over-year.
- Neuphoria Therapeutics Inc. investment income, interest for the quarter ending 2025-09-30 was $142.00K, a 293.38% increase year-over-year.
- Neuphoria Therapeutics Inc. investment income, interest for fiscal 2026 was $665.57K, a 299.75% increase from fiscal 2025.
- Neuphoria Therapeutics Inc. investment income, interest for fiscal 2025 was $166.50K, a 24.35% decline from fiscal 2024.
- Neuphoria Therapeutics Inc. investment income, interest for fiscal 2024 was $220.10K, a 31.89% decline from fiscal 2023.
- Neuphoria Therapeutics Inc. investment income, interest for fiscal 2023 was $323.16K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $170.09K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-18 | $356.26K derived: sum of 2 quarters · filed 2026-09-18 | $523.58K derived: sum of 3 quarters · filed 2026-09-18 | $665.57K 10-K · filed 2026-09-18 |
| 2026-03-31 | $186.17K 10-Q · filed 2026-05-15 | $353.48K derived: sum of 2 quarters · filed 2026-05-15 | $495.48K 10-Q · filed 2026-05-15 | $582.52K derived: sum of 4 quarters · filed 2026-09-18 |
| 2025-12-31 | $167.31K 10-Q · filed 2026-02-17 | $309.31K 10-Q · filed 2026-02-17 | $396.35K derived: sum of 3 quarters · filed 2026-09-18 | $409.09K derived: sum of 4 quarters · filed 2026-09-18 |
| 2025-09-30 | $142.00K 10-Q · filed 2025-11-14 | $229.04K derived: sum of 2 quarters · filed 2026-09-18 | $241.78K derived: sum of 3 quarters · filed 2026-09-18 | $272.40K derived: sum of 4 quarters · filed 2026-09-18 |
| 2025-06-30 | $87.05K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-18 | $99.79K derived: sum of 2 quarters · filed 2026-09-18 | $130.40K derived: sum of 3 quarters · filed 2026-09-18 | $166.50K 10-K · filed 2026-09-18 |
| 2025-03-31 | $12.74K 10-Q · filed 2026-05-15 | $43.36K derived: sum of 2 quarters · filed 2026-05-15 | $79.45K 10-Q · filed 2026-05-15 | $105.78K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $30.61K 10-Q · filed 2026-02-17 | $66.71K 10-Q · filed 2026-02-17 | $93.04K derived: sum of 3 quarters · filed 2026-02-17 | $145.65K derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-09-30 | $36.10K 10-Q · filed 2025-11-14 | $62.42K derived: sum of 2 quarters · filed 2025-11-14 | $115.04K derived: sum of 3 quarters · filed 2025-11-14 | $169.75K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $26.33K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | $78.94K derived: sum of 2 quarters · filed 2025-09-29 | $133.66K derived: sum of 3 quarters · filed 2025-09-29 | $220.10K 10-K · filed 2025-09-29 |
| 2024-03-31 | $52.62K 10-Q · filed 2025-05-20 | $107.33K derived: sum of 2 quarters · filed 2025-05-20 | $193.77K 10-Q · filed 2025-05-20 | |
| 2023-12-31 | $54.72K 10-Q · filed 2025-02-14 | $141.16K 10-Q · filed 2025-02-14 | ||
| 2023-09-30 | $86.44K 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | $323.16K 10-K · filed 2024-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |